... in Internal Medicine Daniel Lai The Leonard P. Tow Humanism in Medicine Award Tahj Ali Blow Teaching Awards...
https://alumni.weill.cornell.edu/programs-events/news/convocation-recognizes-medical-students-achievement
... Moronta The Paul Sherlock Prize in Internal Medicine Daniel Lai The Leonard P. Tow Humanism...
https://news.weill.cornell.edu/news/2023/05/convocation-recognizes-medical-students-achievement
... of several years. Dr. Bishoy Faltas, the Gellert Family-John P. Leonard, M.D. Research Scholar...
https://news.weill.cornell.edu/news/2023/12/awards-honors-december-2023
... at Weill Cornell Medicine, including Drs. Peter Martin, John Leonard, Leandro Cerchietti, Giorgio...
https://gca.weill.cornell.edu/news/adding-epigenetic-drug-standard-chemotherapy-was-effective-pilot-study-t-cell-lymphoma
..., John Leonard, Leandro Cerchietti, Giorgio Inghirami, Olivier Elemento, and Ari Melnick. Investigators...
https://meyercancer.weill.cornell.edu/news/2023-05-04/adding-epigenetic-drug-standard-chemotherapy-was-effective-pilot-study-t-cell
..., Chadburn A, Wehrli NE, van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L Journal Leuk Lymphoma...
https://cerchiettilab.weill.cornell.edu/publications/eif4e-inhibitor-ribavirin-potential-antilymphoma-therapeutic-early-clinical-data-0
... to Facebook Share to Twitter Share to LinkedIn Share on Email Dr. John Leonard New...
https://news.weill.cornell.edu/news/2004/10/newyork-presbyterianweill-cornell-seeks-patients-with-mantle-cell-lymphoma-for-clinical-trial-with-v
... and physicians want to benefit society,” said Dr. John Leonard, senior associate dean for innovation...
https://news.weill.cornell.edu/news/2025/01/innovators-encourage-scientists-and-physicians-to-dive-into-technology
... infusions of Rituximab and received subsequent infusions every two months. Dr. John Leonard After a year...
https://news.weill.cornell.edu/news/2015/11/new-drug-combination-suggests-promising-treatment-for-mantle-cell-lymphoma
.... Leonard, M.D., and collaborators showed no significant progression-free survival benefit of adding...
https://meyercancer.weill.cornell.edu/news/2017-09-19/phase-ii-study-additional-treatment-patients-non-hodgkin-lymphoma-shows-no
